Investigational Drug Details
Drug ID: | D525 |
Drug Name: | Dava AL-balgham |
Synonyms: | The equal proportions of Nigella Sativa ,Zataria Multiflora, Trachyspermum ammi, Pistacia lentiscus |
Type: | Traditional medicine |
DrugBank ID: | -- |
DrugBank Description: | -- |
PubChem ID: | -- |
CasNo: | -- |
Repositioning for NAFLD: | No |
SMILES: | -- |
InChiKey: | -- |
Molecular Weight: | -- |
DrugBank Targets: | -- |
DrugBank MoA: | -- |
DrugBank Pharmacology: | -- |
DrugBank Indication: | -- |
Targets: | -- |
Therapeutic Category: | anti-inflammatory; Anti Atherogenic; antioxidants |
Clinical Trial Progress: | Clinical trial on-going (IRCT2017073135415N1) |
Latest Progress: | Under clinical trials |

Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
---|---|---|---|---|---|---|---|
L0524 | IRCT2017073135415N1 | Not applicable | Not Recruiting | No Results Available | 17/09/2017 | 22 February 2018 | Details |
Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
---|
Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs | |
---|---|---|---|---|---|
S05 | Anti-inflammatory | inflammatory | Bile acid; TNF-a inhibitor; Dual PPAR-α and -δ agonists; Toll-Like Receptor; (TLR)-4 antagonist; Caspase inhibitor; ASK-1 inhibitor | Ursodeoxycholic Acid; Pentoxifylline; Elafibranor; JKB-121; Emricasan; Selonsertib; | Details |
Article ID | PMID | Source | Title |
---|